BioSpace News Archive

Advanced specialty hospital joins Rarebreed’s growing number of practices

According to a new market report published by Persistence Market Research “Global Market Study on Diagnostic Imaging Devices: Asia-Pacific to Witness Highest Growth by 2020,” the global diagnostic imaging devices market was valued at USD 26,477.1 million in 2014 and is expected to grow at a CAGR of 5.2% from 2014 to 2020, to reach an estimated value of USD 35,793.4 million in 2020.

DLA Piper advised NuVasive, Inc., a San Diego -based medical device company that creates and distributes products for surgical treatment of spine disorders, in its offering of US$450 million aggregate principal amount of 0.375% convertible senior notes due 2025. NuVasive also granted to the initial purchasers of the convertible notes a

Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the Wing-IT clinical trial. The Wingman Catheter crosses peripheral CTOs using an extendable beveled tip that creates a channel to help penetrate, or cross, the occlusion with a guidewire

Today, following recent reports from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), HIMSS announced it is clearly necessary to cancel the 2020 HIMSS Global Health Conference & Exhibition.

New England Peptide, a leading provider of peptides for pharmaceutical research and development, which recently acquired Peptides International, today announced the appointment of Martina Diekmann , Ph.D., to the role of Chief Executive Officer and David Gavlik to the role of Chief Financial Officer.

TORONTO, March 05, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”), a company focused on the research, development and commercialization of novel psychedelic and cannabinoid-based life sciences products, is pleased to announce that, further to its press release of February 12, 2020, the Company has completed its acquisition of all of the issued and outstanding securities in the capital of Psilocin Pharma Corp. (“Psilocin”), a specialty psychedelic sciences company

The Alliance for Connected Care commends Congress for moving to help seniors access telehealth during the Coronavirus emergency without having to leave their homes.

Blue Sprig Pediatrics, Inc. along with Florida Autism Center and Fusion Autism Center announced a transformative partnership to create a top-five national provider and the leading provider in the Southern United States of Applied Behavior Analysis therapy services treating children with Autism Spectrum Disorder.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it will host a conference call and audio webcast on Thursday, March 12, 2020 at 1:30 pm PT / 4:30 pm ET to report its fourth quarter 2019 financial results and provide a corporate update.